SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH L impact

Kiniksa Pharmaceuticals Reports Q3 EPS of $0.56

Valid market news retained in the public archive without immediate LiveCast distribution.

KNSA

Related stories